New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days
Check below for free stories on CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 31, 2014
16:59 EDTNKTRNektar reports Q2 EPS (26c), consensus (37c)
Subscribe for More Information
16:42 EDTVRTXVertex receives European approval for KALYDECO in eight gating mutations
Vertex Pharmaceuticals announced that the European Commission has approved KALYDECO for people with cystic fibrosis ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator gene. KALYDECO was first approved in Europe in July 2012 for people with CF ages 6 and older who have the G551D mutation, which is the most common gating mutation. The eight additional gating mutations included in today’s approval are G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D. In Europe, approximately 250 people ages 6 and older have one of these non-G551D gating mutations.
16:17 EDTJNJPharmacyclics says $60M Janssen milestone payment to be recognized in Q3
Subscribe for More Information
10:35 EDTJNJJohnson & Johnson should get new Zytiga patent shortly, says Wells Fargo
Subscribe for More Information
07:23 EDTJNJJ&J withdrawing laparoscopic power morcellators from market, AP says
Subscribe for More Information
06:55 EDTJCPJ.C. Penney turnaround 'very much underway,' says Piper Jaffray
Subscribe for More Information
06:43 EDTSTRAStrayer announces CFO Mark Brown to retire on March 1, 2015
Brown will be replaced by Daniel Jackson, who is being promoted from his current role as Senior Vice President and Treasurer. Jackson joined Strayer Education in 2003, and has served as Vice President of Finance and Regional Vice President of Operations, among other roles.
06:43 EDTSTRAStrayer reports summer term down 6% to 36,403 compared to 38,627 a year ago
Subscribe for More Information
06:42 EDTSTRAStrayer reports Q2 EPS $1.29, consensus $1.27
Subscribe for More Information
06:10 EDTBMYEli Lilly downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Eli Lilly (LLY) to Neutral saying Alimta upside and the company's pipeline is largely priced into shares at current levels. Citi raised its price target for Lilly shares to $66 from $60 and said it prefers Bristol-Myers (BMY) and Pfizer (PFE) in the U.S.
July 30, 2014
17:12 EDTGRMNOn The Fly: Closing Wrap
Subscribe for More Information
10:36 EDTGRMNGarmin board approves intercompany restructuring
Subscribe for More Information
10:32 EDTCATCaterpillar upgraded to Neutral from Underperform at Tigress Financial
Subscribe for More Information
10:02 EDTGRMNGarmin gaps up at open, turns negative on the session, levels to watch
The shares have reversed lower on the session by 6.3% after opening at $61.56. With price last at $54.06, next support is at $53.12. Resistance is at $54.98.
09:04 EDTGRMN, HESOn The Fly: Pre-market Movers
Subscribe for More Information
07:50 EDTJNJSenate Judiciary Committee to hold a hearing
Subscribe for More Information
07:36 EDTHESHess Corp. boosts share repurchase program to $6.5B from $4B
Subscribe for More Information
07:33 EDTHESHess Corp. reports Q2 adjusted EPS $1.38, consensus $1.18
Subscribe for More Information
07:24 EDTGRMNGarmin raises FY14 gross margin outlook from 54%-55% to approx. 56%
Subscribe for More Information
07:06 EDTGRMNGarmin raises FY14 pro forma EPS outlook to $2.95-$3.05 from $2.50-$2.60
FY14 EPS consensus $2.77. Raises FY14 revenue outlook to $2.75B-$2.85B from $2.6B-$2.7B, consensus $2.71B. The company said, "With strong results in 1H14, we are updating our guidance and now anticipate revenues of $2.75B-$2.85B, improved gross and operating margins and a lower pro forma effective tax rate. Our guidance anticipates promotional pricing for the holiday season, as well as higher spending in marketing and advertising to support new product categories resulting in margins that are lower than what we have experienced in the first half of the year."
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use